Related Experiment Video
Updated: Mar 3, 2026
12:22
A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019
9.0K
Dihydropyridine Derivatives as Cell Growth Modulators In Vitro
Imanta Bruvere1, Egils Bisenieks1, Janis Poikans1
1Latvian Institute of Organic Synthesis, 21 Aizkraukles Str., Riga LV-1006, Latvia.
Oxidative Medicine and Cellular Longevity
|May 6, 2017
Summary
Novel 1,4-dihydropyridine derivatives (DHPs) show varied effects on cancer and nonmalignant cells. Some DHPs exhibit antioxidant and growth-suppressing properties, suggesting potential for cancer therapy or wound healing applications.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Biology
Background:
- 1,4-dihydropyridine derivatives (DHPs) are investigated for their biological activities.
- Understanding DHP effects on cancer and normal cells is crucial for therapeutic development.
- Antioxidant and cytotoxic properties of DHPs are key areas of interest.
Purpose of the Study:
- To evaluate the effects of eleven novel 1,4-dihydropyridine derivatives (DHPs) on cancer and nonmalignant cell lines.
- To compare the antiradical activities of these DHPs with their effects on cell growth.
- To explore the potential of specific DHP groups for selective cancer growth suppression or wound healing.
Main Methods:
- Tested eleven 1,4-dihydropyridine derivatives (DHPs) on HOS, HeLa (cancer), and HMEC, L929 (nonmalignant) cell lines.
- Assessed cell growth inhibition using 3H-thymidine incorporation.
- Measured antiradical activity via DPPH assay, using diludine as a reference antioxidant.
Main Results:
- DHPs were categorized into three groups based on their chemical structure.
- Diludine and Group 3 DHPs demonstrated antiradical activity, unlike Group 2 DHPs.
- Novel DHPs exhibited cell type and concentration-dependent effects on cell proliferation; IB-32 (Group 2) suppressed cancer cell growth, while K-2-11 (Group 3) enhanced growth in all cell lines.
Conclusions:
- Novel DHPs display diverse biological activities, including antioxidant and differential growth modulation.
- Group 2 DHPs warrant further investigation for selective anticancer efficacy.
- Group 3 DHPs show potential for applications in wound healing due to their growth-promoting effects.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:39Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K